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Abstract
Background: Few studies have explored patients’ experiences of treatment for CFS/ME. This study aims to fill this
gap by capturing the perspective of patients who have been treated by NHS specialist CFS/ME services in England.
Methods: Semi-structured interviews were conducted during the period June–September 2014 with 16 adults who
were completing treatment at one of three outpatient NHS specialist CFS/ME services. Interviews were analysed
thematically using constant comparison techniques, with particular attention paid to contrasting views.
Results: Three themes were identified: ‘Journey to specialist services’; ‘Things that help or hinder treatment’; and
‘Support systems’. Within these themes nine sub-themes were identified. A wide range of factors was evident in
forming participants’ experiences, including personal characteristics such as perseverance and optimism, and service
factors such as flexibility and positive, supportive relationships with clinicians. Participants described how specialist
services played a unique role, which was related to the contested nature of the condition. Many participants had
experienced a lack of validation and medical and social support before attending a specialist service. Patients’
experiences of life before referral, and the concerns that they expressed about being discharged, highlighted the
hardship and obstacles which people living with CFS/ME continue to experience in our society.
Conclusions: The experiences of CFS/ME patients in our study showed that NHS specialist CFS/ME services played a vital
role in patients’ journeys towards an improved quality of life. This improvement came about through a process which
included validation of patients’ experiences, acceptance of change, practical advice and support, and therapeutic outcomes.
Keywords: Chronic fatigue syndrome, Patient experience, NHS England, Qualitative
Background
Chronic Fatigue Syndrome (CFS), also known as ‘ME’, is a
long-term disabling condition characterised by debilitating
fatigue of unknown cause, post-exertional malaise, cogni-
tive dysfunction and disturbed/unrefreshing sleep, plus
other symptoms including muscle and joint pain, head-
aches, and dizziness [1]. CFS/ME imposes an immense
burden on patients, carers and families [2, 3]. In the UK,
adults who attend NHS specialist CFS/ME services have
been ill for a median duration of 3 years, and half of those
who were employed at the onset of their illness have
ceased working [4].
Around 8000 patients are treated annually by NHS
specialist CFS/ME services in England [5]. There are
approximately 50 such services in England, many of which
were established under the CFS/ME Service Investment
Programme (2004–2006) [6]. These services follow
guidance provided by the National Institute for Health &
Care Excellence (NICE), including specific guidelines for
diagnosis, specialist care, and ongoing management, with
an overall patient-centred approach to treatment [7].
Qualitative studies in CFS/ME have tended to focus
on patients’ experiences of the illness, rather than of care
received [8, 9]. Common thematic areas identified by
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these studies include the high level of functional impair-
ment [10], the specific nature of the fatigue [11], and
issues of coping and identity [12, 13], stigma [14], and
social isolation [15, 16]. Patients generally reported un-
met need in terms of social [17] and medical support
[18]. The thread running through these themes is the
contested nature of CFS/ME [19, 20]. Although the NHS
in England has taken a commendable lead in specialist
care provision for adults with CFS/ME, recognition and
legitimization of the condition across all levels of the
health service remains problematic [21]. An exploration
of patients’ experiences of CFS/ME treatments within
the NHS is timely and exigent, given opposition from
some quarters to evidence-based therapies recom-
mended by NICE and highly discrepant views on the
best approaches to treatment [22].
The aim of our study was to explore the experiences of
CFS/ME patients who were completing programmes of
treatment at three NHS specialist CFS/ME services in
England. We used thematic analysis to analyse semi-
structured interviews in which we asked questions about
the patient journey before, during and at the end of receiv-
ing specialist medical care.
Methods
Study design
We recruited patients who were concluding treatment at
one of three outpatient NHS specialist CFS/ME services in
England. These services follow NICE guidelines for diagno-
sis and management of CFS/ME [7], offering patient-
centred programmes which aim to increase patients’
physical, emotional and cognitive capacities, whilst also
managing the impact of symptoms. Cognitive Behavioural
Therapy (CBT) and Graded Exercise Therapy (GET) are
the two main evidence-based therapies, which (or compo-
nents of which) are used in conjunction with techniques
aimed at managing activity, sleep hygiene and relaxation.
Treatment programmes typically comprise regular (weekly,
fortnightly or monthly) individual and/or group sessions
over a period of 3 to 9 months. Patients also receive prac-
tical support around employment and the benefits system.
Services shared a philosophy of rehabilitation, aiming for
‘recovery’ or ‘significant improvement’, whilst acknowledg-
ing that this would not be attained by all patients. A cross-
sectional design was adopted with an opportunity sample
of 16 patients. Semi-structured interviews were chosen as
the most appropriate way to explore patients’ experiences.
Recruitment
Participants were recruited between July–September 2014.
Patients who completed a course of treatment within this
period were offered a Patient Information Sheet and
‘Consent to Contact’ Form by a clinician involved in their
treatment. Interested patients were required to opt-in to
the study by returning the Consent to Contact Form to the
research team, after which the principal researcher
contacted the patient by telephone to discuss the study in
further detail. Participants were not eligible to participate in
this study if they were: age < 18 years; too severely affected
to be able to participate in interviews; unable to provide
informed consent; unable to read and understand the
Patient Information Sheet and Consent Forms; or not
diagnosed with CFS/ME as a primary diagnosis.
Data collection and analysis
The potential for the research team to influence findings
was carefully considered at all stages of the project [23].
The study adhered to a ‘participatory’ qualitative research
paradigm, using an inductive approach which was driven
by the data, and which did not hypothesise about potential
findings [24]. Researchers were not considered to ‘know
best’, and we followed a collaborative approach between the
research team and participants [25] in which patients
were considered to be ‘experts by experience’ [26]. The
semi-structured interview protocol (see Additional file 1
‘Topic Guide’) was developed through consultation with a
Patient Reference Group affiliated with Action for M.E., a
UK nationwide CFS/ME charity. Participants were offered
the choice of being interviewed in their own home or by
telephone. All interviews began with the open question:
“Tell me about your CFS/ME” and participants were
encouraged to guide discussion and introduce their own
topics of interest. This led to exploration of some topics
not anticipated by researchers. Interviews were audio-
recorded, transcribed and analysed thematically in accord-
ance with guidance by Braun and Clarke [27]. Analysis
began before completion of data collection in order to
ensure that data were as richly detailed and relevant as pos-
sible [28]. Techniques of constant comparison informed
the analysis and the identification of themes [29]. All tran-
scripts were coded thematically by two researchers [JB and
SC], who then used an iterative process (including the use
of a thematic map as a visual aid) to agree a final structure
of themes and subthemes which best represented partici-
pants’ accounts within the remit of the research question.
Results
Participants and interviews
The median age of participants was 43 (range 24–62)
years, 87.5% (14/16) were female, and the median self-
reported duration of illness was 7.5 years (range 1–17)
years. The sample was representative of patients treated
by the 3 services during 2014 (median age 40 years, 81%
(344/424) female), except for a longer duration of illness
(median 2 years). Six participants were interviewed face
to face in their own homes whilst ten participants were
interviewed via telephone. Interview length ranged from
23 min to 57 min, with a mean length of 32 min.
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Themes and sub-themes
Three main themes were identified: (1) ‘Journey to special-
ist service’ (2); ‘Things that help or hinder treatment’; and
(3) ‘Support systems’. Within these themes, 9 sub-themes
were identified (Table 1, Additional file 2 ‘Thematic Map’).
Journey to specialist service
Time taken for referral
Four participants reported that referral to the specialist
service had been a lengthy process, mainly because
diagnostic procedures required ruling out other medical
conditions. The numerous medical tests and appoint-
ments with multiple clinicians was described as being
anything from “hard work” to “very very distressing”.
Four participants discussed having procedures, such as
scans or tests for brain tumours, which were frightening
and “disconcerting”. Not having an answer was in itself
challenging:
“I must have been the only patient in the world who
was in tears when none of the tests said what was
wrong because I just wanted something to sort it
out”[P3]
Participants discussed factors that delayed referral to
specialist services for CFS/ME. Some were initially
misdiagnosed, for example with depression, multiple scler-
osis or glandular fever. Four participants said that ‘watchful
waiting’ periods before symptoms were actively investigated
were difficult:
“I was going in every few weeks and they’d ask if it was
any better and I was like no not really and it was like
okay come back in a few weeks” [P5]
Some participants had felt the need to “hide” symptoms
of CFS/ME, particularly from their employer, for example
using annual leave to manage symptom flare up for a
number of years:
“I kept it totally secret…and I would just hide on the
[pause] at the times I didn’t feel well…I had this secret
life” [P6]
Role of GPs
All participants were referred to CFS/ME specialist services
by their GPs. Participants reported varied experiences before
referral to specialist services. Participants with positive expe-
riences reported that their GPs had been “very supportive”,
“brilliant” and “fantastic”; they valued ‘being taken seriously’
and recognised the key role that their GP had played:
“I said to her I’m really tired I’ve been in bed for ten
days and I’m sorry to sound pathetic and she was
fantastic because she said no no no we’ll take this
seriously” [P7]
One participant described themselves as “lucky” to
have a supportive GP, because they were aware from
contact with the wider CFS/ME community that other
patients had not had good experiences:
“I went back to my GP who I’m fortunate is very
supportive indeed…when I heard about some people’s
experiences with their GP I was so grateful for the
fantastic GP that I’m lucky to have…because it makes a
tremendous difference” [P9]
Participants with less positive experiences described a
number of barriers to accessing specialist services, in-
cluding a lack of information, having to take a proactive
role in asking for diagnostic tests, and GPs’ lack of
“awareness”, “knowledge” or “belief” in CFS/ME:
“My mum did some research and she asked if it was
ME and he said that there was no such thing” [P14]
Two participants discussed their reluctance to be referred
to specialist services because of misunderstandings and
stigma associated with CFS/ME:
“When my GP said I’d like to refer you I just laughed…
and said, it’s terrible but I did, I said oh isn’t that for
people who don’t like work and she really like growled at
me in a nice way and said I think you’ve got a lot to
learn” [P7]
Diagnosis and validation
Many participants had their CFS/ME diagnosis confirmed
when they were assessed by the specialist services.
Although some participants described feeling “relieved” that
diagnosis provided “an answer” and “ruled out” other
conditions, it was a difficult time for the majority. Partici-
pants recalled feeling “angry”, “distressed”, “frustrated”, and
Table 1 Themes and sub-themes
Theme Sub-theme
Journey to specialist service Time taken for referral
Role of GPs
Diagnosis and validation
Things that help or hinder treatment Personal responses
Acceptance
Service access and flexibility
Support systems Mutual support
Professional support
Post-discharge support
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“fearful”, and that the diagnosis represented “a life
sentence”. The specialist service played a crucial role in sup-
porting patients through this difficult period by providing
information and by validating participants’ experiences:
“it was really nice to feel that um I was being treated
by expert professionals who understood the condition
and were sympathetic to it and were really committed
to helping which was err you know a completely
different experience to my GP to be honest” [P2]
Accepting diagnosis of a contested condition was difficult
for some, because of participants’ own negative preconcep-
tions about CFS/ME and the reactions of others. These
participants discussed feeling under pressure to “convince”
or “prove” the validity of their experiences:
“When the doctor suggested as a diagnosis I, um I don’t
know…it was like this huge blow and very distressing. The
only times I’d heard anyone talk about ME CFS
Fibromyalgia it was in very very negative terms, either very
sceptical or friends of my mother…who you know she’d talk
about being bedridden for years and um how tragic their
lives were [laughs] and um I didn’t want to be part of any
of those things and…I didn’t see how I could convince other
people…I just thought no-one’s going to believe I’m ill…I’m
not sure I believe I’m ill” [P6]
Many participants recalled having a limited understand-
ing of CFS/ME prior to accessing specialist services, having
received little or conflicting information about the illness.
For many participants, specialist services provided informa-
tion and explanation of CFS/ME, simultaneously validating
and normalising participants’ experiences and symptoms:
“It was only after I got referred that an explanation was
actually given…that it was actually properly described
to me and that it was told this is what it is this is what
it does to you” [P12]
Things that help or hinder treatment
Personal responses
Although all participants felt that they had benefited from
accessing the specialist service, half recalled finding initial
stages of treatment difficult. Many discussed personal re-
sponses they believed were key to overcoming challenging
periods during treatment. Characteristics described included
being “open”, “positive”, “proactive”, “willing to try anything”,
being able to take “a leap of faith”, and having “perseverance”.
Participants explained that, particularly during early
stages of treatment, advice given by clinicians felt counter-
intuitive, and was a departure from the way that symp-
toms and ‘boom and bust’ cycles had been self-managed
prior to accessing services:
“I said I would rather do something when I can even if it
means that I end up in bed for a week afterwards
because at least I’ve achieved something…I said I’d
rather be asleep and I’ve done something than never do
anything” [P14]
Participants who undertook treatment which involved
limiting activity struggled with the restrictive and slow
progress that this permitted, describing it as “dishearten-
ing”, “painful” and “frustrating”:
“I was like I don’t want to do baby steps I don’t want
to do ten minutes at a time…I wanna be normal and
do what I used to do two months ago…so in the
beginning it was hard” [P1]
“To hear that limitation is very hard… almost can’t
breathe sort of overwhelming” [P9]
Acceptance
A second sub-theme highlighted the importance of accept-
ance in obtaining the most benefit from treatment. Partici-
pants discussed a need to accept changes to their lives as a
result of developing CFS/ME, and reflected upon what they
had lost or relinquished, including social networks, employ-
ment, career and study aspirations, and independence:
“I couldn’t go to university no more because I’d not got
my A Levels I couldn’t finish my A Levels at that point
I couldn’t work so I couldn’t earn any money at that
point…I couldn’t go travelling cause I was too unwell
so I literally [pause] everything that I’d planned in my
life I couldn’t do-I couldn’t do any of it I had to
change change everything and I’m now in a completely
different situation to what I had planned” [P12]
One patient talked about acceptance of their illness in
terms of loss and bereavement:
“You have to go through the grief you have to go
through the loss the bereavement the anger the distress
of losing so much because you do lose a tremendous
amount” [P9]
The majority of participants recalled having had spe-
cific hopes and expectations of referral and treatment,
including to confirm diagnosis, “reduce symptoms”, ob-
tain “answers”, and manage symptoms better. The most
frequently discussed hope prior to accessing specialist
services was for a “cure”, a return to previous health or
abilities, or to “get back to what I was used to”:
“My expectations were quite high when I started
thinking it’s going to sort me out, they’ve found out
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what I’ve got now it’s going to sort it out, but it’s not
that way” [P8]
Participants described a “big” or “steep learning curve”
during early stages of treatment, highlighting the import-
ance of being “willing to change” and being prepared to
“say goodbye to your old life completely” in order to en-
gage fully with treatment. Five participants discussed
needing to overcome initial scepticism about the likeli-
hood of treatment success:
“I just remember looking at (clinician) and looking at
my husband and just going oh whatever” [P1]
Some participants attributed their early hopes and
expectations to lack of knowledge about CFS/ME and to
being unsure about what to expect from a specialist service.
The information about CFS/ME provided by the specialist
clinics was valued by many, but focus on management
remained difficult whilst hopes for a cure remained:
“It’s just frustrating because nothing makes it better I
suppose…it was good getting the information but it
doesn’t get rid of it” [P14]
Time appeared to influence acceptance, with some
participants recalling a gradual acceptance that treat-
ment might not be curative:
“Obviously you know there isn’t some kind of magic
potion or anything that helps you get better…but
managing your ME and managing the kind of boom-
bust that they talked about and putting in kind of
regular resting breaks or Mindfulness or you know
whatever’s helpful, I think those kind of things are the
best way of-of supporting yourself so that you can
function normally and get- you know get through life
as normally as possible” [P10]
Various approaches were used by clinicians to assist
with setting goals, including addressing expectations of
cure at the patient’s first appointment, delaying discussion
until some progress had been made, providing informa-
tion advising participants of the long term nature of CFS/
ME, and being “open” and “honest” about the limitations
of treatment. Moving away from the idea of cure towards
goals related to management of CFS/ME was linked to
obtaining information and acquiring knowledge about the
condition:
“there’s always a silver lining…I would argue that I
live life fully in the slow lane now, and that’s quite a
nice way to be…and I know if I go out into the fast
lane there will be consequences, but I can make that
choice sometimes I will choose to go out into the fast
lane to do something but then I know it’s, you know
there might be a relapse or, or I’ll have to have a
couple of days just not doing much at all…but that’s
management” [P9]
Participants recalled that clinicians also assisted with
and encouraged the development of new goals which
had not been held prior to accessing specialist services.
Some viewed these as vital to treatment success, repre-
senting a shift in focus towards management rather than
cure. Changing goals was recognised as a “slow” and
challenging process. New goals were described as
“smaller”, “a lot more realistic” and “more sensible”, in-
volving the “breaking down” of existing goals, lowering
expectations and focusing on the “day to day” rather
than the future:
“[things] that once seemed the small things perhaps
become the big things…it’s having to change your
whole mind-set really which most of us don’t do
unless we’re pushed into a crisis but it didn’t happen
overnight” [P13]
Service access and flexibility
Participants discussed accessibility in terms of being able
to attend appointments and accommodate treatment
programmes around other commitments. The majority
of participants were pleased with the practical accessibil-
ity of clinics, describing journeys as being “manageable”
or “easy”. However, all participants mentioned that
accessibility could be a barrier to attendance. Whilst all
reported that ease of access to the clinic improved over
time as symptoms improved, travel during the early
stages could be “incredibly hard”, with participants find-
ing the journey “stressful” and “quite troublesome”, and
needing to recover after attending appointments:
“It was quite difficult because it’s 40 minutes from
home so it was a really tiring journey…made it quite a
long day…I was usually asleep for a couple of days
afterwards” [P14]
Some discussed the importance of good public transport
links to the specialist service, whilst others felt that they
would not have been able to attend appointments without
use of a car. Some participants discussed a need for assist-
ance to attend appointments, including help from partners
or friends, particularly when symptoms were severe:
“In the early days we were able to arrange
appointments around [my husband’s] diary so he was
able to take me…‘cause I didn’t feel I was able to
manage the bus” [P16]
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Others said that work commitments could be a barrier
to attending appointments, one patient describing how
it had been a struggle to arrange time off work to attend
the specialist service:
“my appointments were generally on days I didn’t
work and the two day thing I managed to get, finally,
because I was outed as, you know, they put me down
as a disabled employee, which you know I didn’t want,
but it allowed me to get this time” [P6]
Participants noted that accessing the clinic would have
been difficult if experiencing severe symptoms, and con-
cerns were raised about the ability of those severely af-
fected by CFS/ME to access specialist services:
“The severely affected people with ME…a forgotten
group of people who are invisible and that’s a group
of people who really really need that help, which
they’re not getting…because they wouldn’t be able to
get to it” [P9]
Flexibility in the frequency and mode of appointments
was valued by participants, with two participants saying
that they appreciated being offered later appointments
because of travel burden and symptom fluctuation:
“In the beginning it was quite hard but they were
always really good ‘cause I used to struggle in the
mornings the mornings used to be my hardest time so
they were really good at giving me afternoon
appointments” [P1]
The option to have some appointments by telephone
was highly valued, particularly when symptom severity
or travel problems made attendance difficult:
“I remember ringing up to cancel because I couldn’t
get a lift and they suggested [a telephone appointment]
I hadn’t realised we could do that but it was really
really useful” [P16]
Two participants mentioned Skype as a possibility.
One had used Skype as part of a clinical trial and felt
that it provided “an improvement on a phone call”, but
that it would not be appropriate to replace all face to
face sessions with Skype.
Support systems
The third theme identified during analysis related to
systems of support that participants felt were an important
aspect of their experiences at the specialist services. Within
this theme we identified three sub-themes; ‘Mutual support’,
‘Professional support’ and ‘Post-discharge support’.
Mutual support
Nine participants attended only one-to-one treatment
sessions with clinicians at the specialist services, and
seven attended a mix of individual and group ses-
sions. Despite generally strong positive recollections
of group experiences, many participants had initially
held negative perceptions about what groups would
entail, leading participants to feel reluctant or “dubi-
ous” about attending group sessions. Participants
recalled worrying about groups being “touchy-feely”,
pressure to disclose “things that are more personal
that maybe you wouldn’t want to share in a group”,
that group members might “bring each other down”
or “take on other people’s traumas”, and not wanting
to “hang out with a bunch of sick people”:
“At the time I had this vision of just sitting in a room
with people and we would all be talking about our
ailments and I thought that’s not gonna help me” [P16]
One participant had wanted to access one-to-one ses-
sions but was unable to do so because of a long waiting list:
“I don’t really like do lots of social situations and
group things but I was told in no uncertain terms that
it’s either the group thing or you’ll wait years and
years for individual ones so I thought okay I’ll go for
the group one” [P15]
The majority of participants recalled group sessions posi-
tively, with benefits including: relating to other patients; the
opportunity to share experiences and “stories”; receiving
support from group members; supporting others; hearing
about others’ experiences; and having their own personal
experiences and symptoms validated and normalised:
“Listening to other people’s stories and realising um
that other people were experiencing exactly the same
thing and I wasn’t imagining it and it wasn’t all in my
head and I wasn’t being weak I wasn’t being pathetic I
wasn’t being lazy” [P7]
Some participants thought it important that a group”
clicked” or “gelled” in order for the benefits of mutual
support to be realised. In particular, use of humour and
having “things in common” were recalled as facilitators
of group bonding:
“I went into a room with about a dozen other people…
all different ages backgrounds sort of thing…and then
we went round and shared our stories…and it was
quite an eye-opener really how different we all were
and how the illness affected us each differently but we
were all there with this common condition” [P11]
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Professional support
Relationships with clinical staff working for the CFS/ME
service were highly valued by participants, particularly
those accessing one-to-one treatment sessions. Many par-
ticipants had positive experiences and comments about the
clinicians they had worked with. Staff were described as
“patient”, “compassionate”, “reassuring”, “knowledgeable”,
“inspiring”, “friendly”, and “helpful”, ensuring that partici-
pants felt “comfortable”, “at ease”, “valued”, “supported” and
treated “as an equal and an individual”. Participants
described feeling able to be unguarded, and discussed the
value and importance of being believed:
“I could relax and I could tell her how I felt without
feeling like she’s going to dismiss me and I could you
know…use humour if I wanted I could swear if I
wanted…I realised I didn’t have to worry she was
thinking aha you know like looking into my mind to
see what was really going on” [P6]
Two participants contrasted their positive experience
with clinicians at the specialist service with negative pre-
vious healthcare experiences:
“I’ve seen a lot of different doctors and things and
because they don’t understand the condition it doesn’t
really feel like they care very much and they’ve got
other patients to deal with and they don’t have time…
so it’s really refreshing to meet someone who
understands it and who really cares you know they
really believe what you experience some people think
it’s still in your head and things and it’s a bit
patronising” [P10]
Post-discharge support
For some participants, completion of a treatment
programme meant the end of contact with the service.
Some discussed this positively, with one participant “feel-
ing ready” and another, who had “significantly improved”,
feeling “happy”. One participant felt that it was a natural
progression – “you’ve kind of flown the nest [laughs] you’re
being set free” – and another said that they’d had “a pretty
good bite of the cherry really”. However, the majority of
participants (10/16) were worried about their ability to
cope following discharge, and were concerned about the
level of support that would be available:
“The biggest thing I’m missing and I’m sure a lot of
people would say the same is just having um some
support after the course” [P10]
Some participants had been advised that they could
contact the service by telephone should they require fur-
ther support or re-referral:
“I’ve just been discharged but there’s a safety net in
that they said we don’t just drop you, if you need help
or if you’re struggling then don’t be a stranger just pick
up the phone” [P13]
Others had been offered a review appointment 6–
12 months after completion of treatment, although this
follow-up did not assuage concerns about life after
discharge:
“Like there isn’t any [aftercare] you do your ten
sessions and that’s it…you can speak to somebody
within six months but you just get to speak to
somebody and that’s it you can ask to be referred
again but the waiting lists are that big considering
you’ve done it once I don’t know whether or not you’d
get to do it again” [P15]
Specialist services were seen to provide “reassurance”,
“backup” and were viewed as a “security blanket”, “safety
blanket” or “lifeboat”. Some participants said that they
would prefer to err on the side of caution and retain links
with the service:
“The occupational therapist asked me how I was
feeling and I said the same thing you know the
mixed emotions thing and she sort of asked well
what would make you feel better and I was like oh
I don’t know…maybe knowing that if I needed to
come back I could” [P1]
Some felt that they would miss the routine and struc-
ture of attending the service – “quite a regular part of
my week” – or would struggle to maintain progress
independently:
“That would be really nice if we could like have a
regular kind of meet up…just to check in and see how
you’re doing what your progress is if you need any
support or things like that…because otherwise you feel
like you learn these tools and then you’re kind of left
out in the open a bit” [P10]
Strong negative reactions to discharge were expressed
by several participants in the context of their experi-
ences before attending the specialist service, when they
had felt unsupported by GPs, family, friends, colleagues
and employers, and had experienced stigma and lack of
understanding:
“When the specialist discharged me I uh I’m not
blaming him but I was left feeling very alone-the
illness itself makes one quite um [pause] lonely because
uh social activity’s quite tiring” [P11]
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These strong reactions included fears about relapse
and being “abandoned”, a sense of “panic” and even
“bereavement”:
“It’s like you’re having another bereavement cause like
this thing has changed your life…it would have been
better if you could maybe have known you could go up
there for maybe like top-ups once a month or once
every 3 months just so you wasn’t like you’ve had those
sessions you’re fixed goodbye” [P15]
Some of the mutual support systems developed be-
tween patients were maintained post-discharge. Partici-
pants from one of the specialist services discussed
arranging their own meetings independently from the
clinic following completion of treatment:
“Our group meet every couple of months so we’re all
supporting each other really” [P8]
Discussion
This is the first study to provide an insight into the experi-
ences of adult patients who have attended NHS specialist
services for CFS/ME. Our study reiterates the challenges
faced by CFS/ME patients, and reveals the important and
unique role that specialist services can play in the lives of
people living with CFS/ME. Participants described lengthy
and often difficult journeys to reaching a specialist service,
and reflected on the challenges posed by the contested
nature of CFS/ME. Convoluted diagnostic pathways and
lack of validation were particularly challenging obstacles
en route to referral, compounded by lack of social and
professional support.
NHS specialist CFS/ME services have evolved to deliver
programmes of treatment that enable patients to embark
on a process of rehabilitation. The services in our study
shared a philosophy of aiming for recovery or ‘significant
improvement’, whilst acknowledging that this would not
be attained by all patients, that ‘recovery’ would mean dif-
ferent things to different people, and that talking about a
patient’s pre-illness lifestyle could be part of the thera-
peutic process. The process demands effort and commit-
ment from patients, but the experiences of patients in our
study demonstrate the potential for improving patients’
quality of life. This has been demonstrated quantitatively
[30], but our study illustrates what changes in numeric
questionnaire scores actually mean for patients, and what
patients have to go through to achieve that improvement.
All participants reported having benefited in some way
from accessing specialist services, and their accounts
highlighted factors which appear to mediate the success of
treatment programmes. These factors include participants’
own reactions and attitudes towards treatment, which were
deemed crucial in fostering engagement and perseverance
during the difficult early stages of treatment. Many dis-
cussed the importance of acceptance and the use of goal
setting to navigate adaptations to a life with chronic illness.
The role played by clinicians at the specialist services was
recognised and highly valued by participants.
Discussion of participants’ reactions to discharge iden-
tified the specialist services as a source of long-term
support for participants, with participants’ realism and
optimism for the future being tinged with fears about
disconnecting from services. These concerns were par-
ticularly acute for those patients who had encountered
the greatest difficulties in obtaining specialist treatment.
Our findings in the context of previous studies
We don’t have figures for the proportion of the ‘clinical
iceberg' visible in secondary care, but we assume that not
all adults with CFS/ME access specialist services. Most
areas of England have geographical access to a specialist
service [5], but it is evident from the experiences of
patients in our study that barriers to access remain. With-
out conducting a comparative study, we don’t know to
what extent the participants in our study might be consid-
ered ‘the lucky ones’, i.e. people who have accessed a spe-
cialist service and completed a programme of treatment.
Nonetheless, there is a reasonably rich seam of qualitative
literature around patients’ and health care professionals’
experiences of CFS/ME, if not of treatment per se.
Journey to specialist service
One part of the patient journey emerged as a main
theme in adult patients’ experiences of services, namely;
the long and often tortuous path through primary care,
beginning with the patient’s own gradual recognition
that something was “just not right”, through inconclusive
and negative tests, misdiagnoses, and lack of informa-
tion, before finally being referred to a specialist service.
This long and difficult journey to specialist care has been
described by parents of paediatric CFS/ME patients [31].
NICE guidance states that “Referral to specialist CFS/
ME care should be offered: within 6 months of presenta-
tion to people with mild CFS/ME; within 3-4 months of
presentation to people with moderate CFS/ME symp-
toms; immediately to people with severe CFS/ME symp-
toms” [7]. The median duration of illness in our sample
was 8 years, with a range of one to 17 years.
Our study showed that negative experiences early in
the patient journey can arise partly from patients’ own
perceptions of CFS/ME. Although these are likely to
reflect societal attitudes to CFS/ME, thereby posing a
somewhat intractable problem, GPs and other primary
health care professionals clearly have an important role
to play in addressing delegitimization and misinforma-
tion, and in improving the standard of care. This was
evident in the positive experiences of those patients in
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our study who were believed and supported by well-
informed GPs. Being diagnosed with CFS/ME triggering
a range of emotions in patients. Practitioners in special-
ist services might be best-placed to support patients at
this stage in their journey [21], but the key elements in
providing that support – information, explanation, valid-
ation, empathy – are within the remit of patient-centred
primary care.
Things that help or hinder treatment
Of the underlying themes relating to entry into and
subsequent engagement with treatment, perhaps the
most fundamental was ‘acceptance’. Patients’ accept-
ance of changes, to their lifestyle and identity, was
particularly important in helping patients negotiate
the difficult early stages of treatment. Acceptance and
identity are recurring central themes in qualitative
studies of CFS/ME [8, 9, 12, 13]. These are themes
common to chronic illness, but certain aspects of
CFS/ME – the long journey to diagnosis, the con-
tested nature of that diagnosis [19, 20], the responses
of society [17] and significant others [16, 32], varied
symptomatology [1], unknown aetiology, and broad
age range of those affected [33] – present particular
challenges to patients and clinicians.
Patients’ views about personal responses that are con-
ducive to overcoming challenges during treatment can
be loosely mapped to known predictors and mediators
of treatment outcomes. These include acceptance and
neuroticism [34], the acceptability of expressing emo-
tions [35], fear and embarrassment avoidance [36, 37],
all-or-nothing behaviour [37], beliefs around activity and
inactivity [10], sense of control over symptoms [38, 39],
and ‘psychological flexibility’ [40]. Ideally, a patient-
centred approach to treatment will accommodate diverse
personal responses and behaviours.
The goal attainment approach used by services, and
commented upon as one of the more challenging aspects
of treatment, has been associated with improvement in
quality of life in CFS/ME patients regardless of initial
health status [41]. The effectiveness of this approach, in
conjunction with other factors such as services’ attention
to detail around issues such as accessibility and flexibil-
ity, would contribute to favourable views of services
among patients. ‘Alternative’ approaches to treatment,
such as accepting the legitimacy of patients’ accounts of
their illness and providing realistic expectations of treat-
ment outcomes [42], have already been adopted, and our
study confirms that referral to a specialist service is
highly valued [43].
Support systems
The therapeutic relationship, encapsulated in the ‘Profes-
sional support’ subtheme, will clearly be of importance in
predicting treatment outcomes, with one study in
CFS/ME treatment indicating ‘positive outcome ex-
pectations’ and ‘task agreement’ as being important
during the early stages [44]. One element of treat-
ment which was particularly valued by participants was
normalisation of experience through attending group
based treatment programmes. This reflects the legitimisa-
tion and validation which appeared key to participants’ en-
counters with others in group therapy [45]. It was clear
that group sessions, despite initial reluctance and wari-
ness, began to offset individual experiences of isolation
prior to referral.
Strengths and limitations
Our study strikes a balance in capturing differences and
similarities between patients in terms of their experi-
ences of NHS specialist CFS/ME services. The partici-
pants in our study were recruited from specialist
services in three quite different settings – London, the
south west and the north west of England – but these
services can be considered broadly representative of the
larger (>250 patients per year) specialist services in
England. Similarly, all participants were diagnosed and
treated in accordance with UK NICE guidelines [7], but
between-service variation in the structure and content of
treatment programmes, and the patient-centred ethos of
the guidelines, means that the patients in our study did
not all receive exactly the same course of treatment. We
did not seek to explore patients’ experiences of specific
treatments or components of treatment programmes
such as CBT and GET.
The size of our opportunity sample was constrained by
resources, and was at the lower end of what might be con-
sidered sufficient to obtain saturation in all topics [46].
Interview length was constrained partly by the time avail-
able to conduct the study, but we were also mindful of not
wanting to over-exert patients who may still be having to
self-manage their activities, including cognitive exertion.
The topic guide was arrived at through consultation with
the Action for M.E. patient reference group, which gave
us some reassurance that we were able to cover the main
topics within the allotted time. Although we captured a
range of patient experiences in a sample which was het-
erogeneous and broadly representative of patients who ac-
cess NHS specialist CFS/ME services in terms of age and
sex, the patients in our sample reported longer durations
of illness. Patients who are ill for a shorter period of time
before referral may experience specialist services quite dif-
ferently, particularly in relation to sub-themes such as
‘Time taken for referral’ and ‘Acceptance’. Our sample was
too small to explore patients’ experiences of specialist
services in relation to the ME/ME, or in the presence of
comorbidities such as depression and fibromyalgia [1].
Our remit to explore the experiences of the ‘majority’ of
Broughton et al. BMC Health Services Research  (2017) 17:384 Page 9 of 12
CFS/ME patients meant that we excluded severely affected
patients. These patients merit special research attention,
given the severity of their illness [47, 48] and specific
issues such as lack of domiciliary care provision [49].
These sampling issues are likely to restrict the
generalizability of our findings to all CFS/ME patients.
Similarly, patients attending smaller CFS/ME services may
have different experiences from those who participated in
our study.
The other principal limitation of our study is that we
recruited patients who had reached the end of treatment.
This means that the positive experiences that we have
reported could be considered to represent ‘success stories’.
We do not have figures for drop-out rates, which might
reflect dissatisfaction with services and/or competing health
issues. We would propose interviews with patients who do
not complete treatment as an important area for future
qualitative research. Our findings are susceptible to selec-
tion bias if patients were motivated to participate by a sense
of gratitude and an altruistic desire to ‘give back’ to the
clinic after a positive experience. We know that black and
minority ethnic groups are under-represented among
patients attending specialist CFS/ME services [17, 50], and
people living with CFS/ME in these population groups may
have different or particular experiences [51]. Finally, the
long-term course of CFS/ME after treatment is not well-
characterized, either quantitatively or qualitatively. We
would need to repeat our study with a sample of patients
several years post-treatment to explore whether positive
outcomes at the end of treatment translate into recovery or
sustained improvement in quality of life. Finally, alternative
methods of analysis, such as Interpretive Phenomenological
Analysis, may have given a different focus to our analysis.
We trust that our thematic approach will create a frame-
work for further qualitative research within this area.
Implications for health services
Although knowledge and awareness of CFS/ME in pri-
mary care has improved over the past decade [21], it is
clear from our study that some patients still have negative
experiences. Some of these stem from uninformed health
care professionals, and lack of confidence that non-
specialists have in making a diagnosis [52, 53]. These
problems are not unique to the UK [18, 54], and initiatives
based on better provision of information for GPs [55, 56],
changes to medical training [57] and ‘early intervention’
[58] could be applied across health systems.
Patients’ pre-treatment experiences gave rise to strong
feelings about being discharged, with many fearing a
future in which they were no longer connected to the ser-
vice. Although some services addressed this by offering
review appointments and telephone contact, long-term
support is one aspect of service provision which is not
covered by current guidelines. One of the services pro-
vided ‘Moving Forward’ and ‘Relapse Prevention’ plans
towards the end of treatment. The Moving Forward plan
was based on questions such as “What are my next
steps?”, “How will I achieve these?”, “What may get in the
way?”, and “How will I deal with them?” The Relapse Pre-
vention plan comprised a ‘CFS/ME Toolkit’ (helpful strat-
egies learnt in sessions), ‘Relapse Signature’ (early signs of
relapse), and ‘Relapse Drill’ (what do I need to do when I
experience signs of relapse). Some patients had continued
to meet in informal self-support groups, an arrangement
which might benefit from formal professional support
[59]. Our study showed the benefit to patients of profes-
sional and social support obtained via the specialist
services, beyond clinical care. This suggests that services
need to be resourced to provide long-term support for
patients, and to be able to focus on long-term pragmatic
outcomes such as return to employment [60]. Novel
means of delivering care, such as graded exercise via tele-
therapy [61], also need to be tested.
Conclusions
The experiences of CFS/ME patients in our study
showed that NHS specialist CFS/ME services had a vital
role to play in patients’ journeys towards an improved
quality of life. This improvement came about through
patients’ acceptance of their illness, therapeutic out-
comes, and practical advice and support. Patients’ expe-
riences of life before referral, and the concerns that they
expressed about being discharged, highlighted the hard-
ship and obstacles which people living with CFS/ME
continue to experience in our society.
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